Saturday, October 31, 2026

Tesla Stock Is 2% Up So Far On Thursday

ViaNews Editorial Team

December 17, 2020

Tesla Stock Is 2% Up So Far On Thursday

Shares of Tesla rose 2.92% to $640.98 at 11:49 EST on Thursday, after two consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 0.54% to $12,727.00, after three sequential sessions in a row of gains. This seems, up to now, a somewhat positive trend exchanging session today.

Tesla's last close was $622.77, 2.08% below its 52-week high of $654.32.

News about Tesla today

Goldman says Tesla inclusion won’t make s&p 500 much pricier. According to today's article on Bloomberg Quint, "Tesla shares have surged 644% this year, pushing the company's market value close to $600 billion, of which about 80% is floating. ", ""Given Tesla's large size and elevated multiple, many investors erroneously intuit that the company's inclusion into the S&P 500 will lift the index's current 22x P/E multiple -- which already registers close to the highest levels on record -- by two multiple turns or more," Kostin and his colleagues wrote. "

Tesla going in s&p 500 is what the smart-beta geeks warned about. According to today's article on Bloomberg Quint, "That demand will be squeezed into an "artificially short time-frame" and further distort prices, given that the funds that benchmark to the index need to make adjustments on the effective date, according to Dimensional Fund Advisors, which has owned Tesla in its funds for the past nine years.", "But at the core of the philosophy is a belief that standard-investing benchmarks are weighed down by just the sort of rules that cause S&P to add Tesla after its market cap swelled by $500 billion in a year."

Tesla only U.S. automaker meeting brake-safety commitment early. According to today's article on Bloomberg Quint, "Tesla Inc. is the lone U.S. automaker to meet a commitment to equip all its models with automatic emergency braking almost two years ahead of schedule, as Detroit automakers lag behind the safety leaders.", "Tesla is among 10 companies that have already fulfilled a promise to federal regulators to install the safety technology on its vehicles by Sept. 1, 2022, according to Consumer Reports magazine and the Insurance Institute for Highway Safety. "

Tesla's Sales

Tesla's sales growth is 35.4% for the present quarter and 59.8% for the next. The company's growth estimates for the current quarter and the next is 114.6% and 265.2%, respectively.

Tesla's Revenue

Year-on-year quarterly revenue growth grew by 39.2%, now sitting on 28.18B for the twelve trailing months.

Tesla's Stock Yearly Top and Bottom Value

Tesla's stock is valued at $640.98 at 11:49 EST, below its 52-week high of $654.32 and way higher than its 52-week low of $70.10.

Tesla's Moving Average

Tesla's value is way higher than its 50-day moving average of $511.20 and way above its 200-day moving average of $378.53.

Previous days news about Tesla

VW CEO pits world’s largest car plant against new Tesla site. According to Bloomberg Quint on Tue Dec 15, "Volkswagen AG Chief Executive Officer Herbert Diess told top managers the German manufacturer will pit its largest plant against the Tesla Inc. factory that's under construction near Berlin, according to people familiar with the matter."

FA center: why Tesla bulls are in the driver’s seat as the stock nears inclusion in the s&p 500. According to MarketWatch on Wed Dec 16, "More: Tesla may be 'most remarkable' stock market 'story of them all', says strategist", "That is the metric I used to construct the table below, which shows the top 10 stocks in a ranking (from highest to lowest) of all S&P 500 stocks. If Tesla"

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com